skip to Main Content
Nghiem Lab
  • Research
  • People
  • Publications
  • News
  • Contact
  • Photo Gallery
  • Search
×Close search
Publications

Merkel Cell Carcinoma: An Unusually Immunogenic Cancer Proves Ripe for Immune Therapy.

Vandeven N, Nghiem P.

J Oncol Pract. 2016 Jul;12(7):649-50.

PMID: 27407162

View on PubMed - View PDF

J Oncol Pract. 2016 Jul;12(7):649-50.
Related Items
Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials
Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis
Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer
  • previous post: PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
  • next post: Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
© Copyright University of Washington · Paul Nghiem Lab - All Rights Reserved 2022
Updated: Aug 22, 2018 @ 5:39 pm
Back To Top